531 related articles for article (PubMed ID: 15019179)
1. The formation of AFB(1)-macromolecular adducts in rats and humans at dietary levels of exposure.
Cupid BC; Lightfoot TJ; Russell D; Gant SJ; Turner PC; Dingley KH; Curtis KD; Leveson SH; Turteltaub KW; Garner RC
Food Chem Toxicol; 2004 Apr; 42(4):559-69. PubMed ID: 15019179
[TBL] [Abstract][Full Text] [Related]
2. Aflatoxin-albumin adducts: a basis for comparative carcinogenesis between animals and humans.
Wild CP; Hasegawa R; Barraud L; Chutimataewin S; Chapot B; Ito N; Montesano R
Cancer Epidemiol Biomarkers Prev; 1996 Mar; 5(3):179-89. PubMed ID: 8833618
[TBL] [Abstract][Full Text] [Related]
3. Modulation of aflatoxin toxicity and biomarkers by lycopene in F344 rats.
Tang L; Guan H; Ding X; Wang JS
Toxicol Appl Pharmacol; 2007 Feb; 219(1):10-7. PubMed ID: 17229449
[TBL] [Abstract][Full Text] [Related]
4. Effects of intermittent exposure to aflatoxin B1 on DNA and RNA adduct formation in rat liver: dose-response and temporal patterns.
Sotomayor RE; Washington M; Nguyen L; Nyang'anyi R; Hinton DM; Chou M
Toxicol Sci; 2003 Jun; 73(2):329-38. PubMed ID: 12700393
[TBL] [Abstract][Full Text] [Related]
5. DNA and protein adduct formation in the colon and blood of humans after exposure to a dietary-relevant dose of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
Dingley KH; Curtis KD; Nowell S; Felton JS; Lang NP; Turteltaub KW
Cancer Epidemiol Biomarkers Prev; 1999 Jun; 8(6):507-12. PubMed ID: 10385140
[TBL] [Abstract][Full Text] [Related]
6. Covalent binding of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline to albumin and hemoglobin at environmentally relevant doses. Comparison of human subjects and F344 rats.
Dingley KH; Freeman SP; Nelson DO; Garner RC; Turteltaub KW
Drug Metab Dispos; 1998 Aug; 26(8):825-8. PubMed ID: 9698300
[TBL] [Abstract][Full Text] [Related]
7. Aflatoxin-albumin adduct formation after single and multiple doses of aflatoxin B(1) in rats treated with Thai medicinal plants.
Vinitketkumnuen U; Chewonarin T; Dhumtanom P; Lertprasertsuk N; Wild CP
Mutat Res; 1999 Jul; 428(1-2):345-51. PubMed ID: 10518006
[TBL] [Abstract][Full Text] [Related]
8. Determinants of aflatoxin levels in Ghanaians: sociodemographic factors, knowledge of aflatoxin and food handling and consumption practices.
Jolly P; Jiang Y; Ellis W; Awuah R; Nnedu O; Phillips T; Wang JS; Afriyie-Gyawu E; Tang L; Person S; Williams J; Jolly C
Int J Hyg Environ Health; 2006 Jul; 209(4):345-58. PubMed ID: 16644281
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis and chronic dosimetry of the aflatoxin B1 plasma albumin adduct Lys-AFB1 in rats by isotope dilution mass spectrometry.
Scholl PF; McCoy L; Kensler TW; Groopman JD
Chem Res Toxicol; 2006 Jan; 19(1):44-9. PubMed ID: 16411655
[TBL] [Abstract][Full Text] [Related]
10. Quantitative comparison of aflatoxin B1 serum albumin adducts in humans by isotope dilution mass spectrometry and ELISA.
Scholl PF; Turner PC; Sutcliffe AE; Sylla A; Diallo MS; Friesen MD; Groopman JD; Wild CP
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):823-6. PubMed ID: 16614131
[TBL] [Abstract][Full Text] [Related]
11. Natural chlorophyll inhibits aflatoxin B1-induced multi-organ carcinogenesis in the rat.
Simonich MT; Egner PA; Roebuck BD; Orner GA; Jubert C; Pereira C; Groopman JD; Kensler TW; Dashwood RH; Williams DE; Bailey GS
Carcinogenesis; 2007 Jun; 28(6):1294-302. PubMed ID: 17290047
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the DNA adduction and pharmacokinetics of PhIP and MeIOx in rodents at doses approximating human exposure using the technique of accelerator mass spectrometry (AMS) and 32P-postlabeling.
Turteltaub KW; Vogel JS; Frantz C; Felton JS; McManus M
Princess Takamatsu Symp; 1995; 23():93-102. PubMed ID: 8844800
[TBL] [Abstract][Full Text] [Related]
13. Identification of aflatoxin M1-N7-guanine in liver and urine of tree shrews and rats following administration of aflatoxin B1.
Egner PA; Yu X; Johnson JK; Nathasingh CK; Groopman JD; Kensler TW; Roebuck BD
Chem Res Toxicol; 2003 Sep; 16(9):1174-80. PubMed ID: 12971806
[TBL] [Abstract][Full Text] [Related]
14. Adduction of biomacromolecules with acrylamide (AA) in mice at environmental dose levels studied by accelerator mass spectrometry.
Xie Q; Sun H; Liu Y; Ding X; Fu D; Liu K
Toxicol Lett; 2006 May; 163(2):101-8. PubMed ID: 16280212
[TBL] [Abstract][Full Text] [Related]
15. Dissimilarity in aflatoxin dose-response relationships between DNA adduct formation and development of preneoplastic foci in rat liver.
Root M; Lange T; Campbell TC
Chem Biol Interact; 1997 Oct; 106(3):213-27. PubMed ID: 9413548
[TBL] [Abstract][Full Text] [Related]
16. Variability in aflatoxin B(1)-macromolecular binding and relationship to biotransformation enzyme expression in human prenatal and adult liver.
Doi AM; Patterson PE; Gallagher EP
Toxicol Appl Pharmacol; 2002 May; 181(1):48-59. PubMed ID: 12030842
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of methods for quantitation of aflatoxin-albumin adducts and their application to human exposure assessment.
Wild CP; Jiang YZ; Sabbioni G; Chapot B; Montesano R
Cancer Res; 1990 Jan; 50(2):245-51. PubMed ID: 2104776
[TBL] [Abstract][Full Text] [Related]
18. Dose-dependent benzo(a)pyrene [B(a)P]-DNA adduct levels and persistence in F-344 rats following subchronic dietary exposure to B(a)P.
Ramesh A; Knuckles ME
Cancer Lett; 2006 Aug; 240(2):268-78. PubMed ID: 16288829
[TBL] [Abstract][Full Text] [Related]
19. Cancer risk assessment for crotonaldehyde and 2-hexenal: an approach.
Eder E; Schuler D; Budiawan
IARC Sci Publ; 1999; (150):219-32. PubMed ID: 10626223
[TBL] [Abstract][Full Text] [Related]
20. Temporal patterns of DNA adduct formation and glutathione S-transferase activity in the testes of rats fed aflatoxin B1: a comparison with patterns in the liver.
Sotomayor RE; Sahu S; Washington M; Hinton DM; Chou M
Environ Mol Mutagen; 1999; 33(4):293-302. PubMed ID: 10398377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
